Journal article

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: A randomised, placebo-controlled phase 2b trial

Abstract:: Background BCG vaccination provides incomplete protection against tuberculosis in infants. A new vaccine, modified Vaccinia Ankara virus expressing antigen 85A (MVA85A), was designed to enhance the protective efficacy of BCG. We aimed to assess safety, immunogenicity, and efficacy of MVA85A against tuberculosis and Mycobacterium tuberculosis infection in infants. Methods In our double-blind, randomised, placebo-controlled phase 2b trial, we enrolled healthy infants (aged 4-6 months) without H...
Expand abstract
Collapse abstract

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Tameris, M. D., Hatherill, M., Landry, B., Scriba, T., Snowden, M., Lockhart, S., Lockhart, S., Shea, J., McClain, J., Hussey, G., Hussey, G., Hanekom, W., Mahomed, H., Mahomed, H., & McShane, H. (2013). Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: A randomised, placebo-controlled phase 2b trial. Lancet, 381(9871), 1021–1028.

MLA Style

Tameris, MD, et al. “Safety and Efficacy of MVA85A, a New Tuberculosis Vaccine, in Infants Previously Vaccinated with BCG: A Randomised, Placebo-Controlled Phase 2b Trial.” Lancet, vol. 381, no. 9871, 2013, pp. 1021–28.

Chicago Style

Tameris, MD, M Hatherill, B Landry, et al. 2013. “Safety and Efficacy of MVA85A, a New Tuberculosis Vaccine, in Infants Previously Vaccinated with BCG: A Randomised, Placebo-Controlled Phase 2b Trial.” Lancet 381 (9871): 1021–28.
Print

Access Document

Publisher copy:: 10.1016/S0140-6736(13)60177-4

Authors

+ Tameris, MD More by this author

Role:: Author

+ Hatherill, M More by this author

Role:: Author

+ Landry, B More by this author

Role:: Author

+ Scriba, T More by this author

Role:: Author

+ Snowden, M More by this author

Role:: Author

More authors...

Journal:: Lancet More from this journal
Volume:: 381
Issue:: 9871
Pages:: 1021-1028
Publication date:: 2013-03-01
DOI:: 10.1016/S0140-6736(13)60177-4
EISSN:: 1474-547X
ISSN:: 0140-6736

Pubs id:: pubs:395232
UUID:: uuid:4715d8d0-0d5f-4a0b-a845-caed92b75086
Local pid:: pubs:395232
Source identifiers:: 395232
Deposit date:: 2013-11-16
ARK identifier:: ark:/29072/ora_4715d8d00d5f4a0ba845caed92b75086

Terms of use

Copyright date:: 2013

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

Views and downloads will return soon

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP